We hypothesize that combining POCT-based measurements of NT-proBNP, D-Dimer, and H-FABP with patient-specific clinical data, will enable pre-hospital identification of LVO in suspected stroke patients with a sensitivity of 50% and a specificity of 92.5%. Here, FABP3 is linked to Stroke.